Company intelligence / Profile preview

Xiamen Boson Biotech

Ownership: Private
Development stage: Commercial

Overview

Xiamen Boson Biotech has developed and commercialized a broad portfolio of rapid diagnostic kits. Notably, its BOSON Rapid SARS-CoV‑2 Antigen Test Card received Emergency Use Authorization from the US FDA in April 2022 after validation by Emory University and MRIGlobal. The test was also the first globally to receive CE certification for self-testing. Products are sold worldwide with regulatory approvals from China NMPA and CE marking.

Therapeutic areas: OncologyInfectious DiseasesOtherPsychiatryCardiovascularWomen's Health
Modalities: Diagnostic kitImmunoassay kitChemiluminescence immunoassay (CLIA)Enzyme-linked immunosorbent assay (ELISA)Colloidal gold qualitative detection reagentAntibody (as raw material/component)Antigen (as raw material/component)
Industry: Protein Biomarker Diagnostics

Partnerships

Participated in NIH RADx program for COVID diagnostics validation; no major pharma/biotech partnerships disclosed.

Beyond the preview

Go deeper on Xiamen Boson Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiamen Boson Biotech.

Explore the full profile